Home › Kidney Cancer
Kidney Cancer clinical trials recruiting in the U.S.
58 studies for Kidney Cancer are recruiting participants at sites across the United States.
Kidney cancer symptoms are hard to detect at first but they do exist. Read more about the top 5 symptoms and the treatment options available
Cities with the most studies
- New York City, NY16 studies
- Boston, MA11 studies
- Nashville, TN11 studies
- Houston, TX10 studies
- St. Louis, MO10 studies
- Edison, NJ9 studies
- Dallas, TX9 studies
- Washington, DC9 studies
- San Diego, CA9 studies
- Los Angeles, CA8 studies
- Seattle, WA8 studies
- Queens, NY7 studies
- Jacksonville, FL7 studies
- Baltimore, MD7 studies
- Staten Island, NY6 studies
- New Rochelle, NY6 studies
- Durham, NC6 studies
- Baldwin Park, CA6 studies
- Rochester, MN6 studies
- Mountain View, CA6 studies
- Miami, FL6 studies
- Aurora, CO6 studies
- Omaha, NE6 studies
- East Norwalk, CT5 studies
- Pittsburgh, PA5 studies
- Columbus, OH5 studies
- Phoenix, AZ5 studies
- Cleveland, OH5 studies
- Greenburgh, NY4 studies
- Portland, OR4 studies
- Detroit, MI4 studies
- Denver, CO4 studies
- San Francisco, CA4 studies
- Highlands Ranch, CO4 studies
- Atlanta, GA4 studies
- Orange, CA4 studies
- New Haven, CT4 studies
- San Antonio, TX4 studies
- Madison, WI3 studies
- Oklahoma City, OK3 studies
By state
- Arizona8 studies
- Arkansas3 studies
- California19 studies
- Colorado9 studies
- Connecticut6 studies
- Florida13 studies
- Georgia5 studies
- Illinois7 studies
- Indiana3 studies
- Iowa4 studies
- Kentucky3 studies
- Louisiana3 studies
- Maryland16 studies
- Massachusetts13 studies
- Michigan6 studies
- Minnesota9 studies
- Missouri11 studies
- Nebraska6 studies
- New Jersey9 studies
- New York18 studies
- North Carolina8 studies
- Ohio10 studies
- Oklahoma4 studies
- Oregon4 studies
- Pennsylvania10 studies
- South Carolina5 studies
- Tennessee11 studies
- Texas17 studies
- Virginia7 studies
- Washington8 studies
- Wisconsin6 studies
Recently updated studies
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT05536141Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer
RecruitingObservational studyHealthy volunteers welcome
Ages 2 and older · All sexes · Updated Nov 12, 2026 · NCT00033137Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer
RecruitingObservational studyHealthy volunteers welcome
Ages 2 and older · All sexes · Updated Nov 10, 2026 · NCT00050752Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
RecruitingObservational studyHealthy volunteers welcome
Ages 2 and older · All sexes · Updated Nov 9, 2026 · NCT00026884Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Nov 5, 2026 · NCT03160274cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RecruitingObservational studyHealthy volunteers welcome
Ages 40 and older · All sexes · Updated Nov 4, 2026 · NCT05366881Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders
RecruitingObservational studyHealthy volunteers welcome
Ages 2 and older · All sexes · Updated Nov 4, 2026 · NCT00001238Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07300241Distance-Based Exercise to Preserve Function and Prevent Disability
Recruiting
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07059884Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT07011719A Study of a Side Effects and Resource Navigation Program for People With Cancer
Recruiting
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT07646847Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT04981119A Study of Treatment Delivery Preference In People With Kidney Cancer
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Oct 16, 2026 · NCT07872553Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
RecruitingObservational studyHealthy volunteers welcome
4 Weeks · All sexes · Updated Oct 16, 2026 · NCT01109394Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)
RecruitingPhase 1/2
Ages 18 to 100 · All sexes · Updated Oct 16, 2026 · NCT05665361Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 15, 2026 · NCT06239194KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 14, 2026 · NCT06026410Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 8, 2026 · NCT07227415[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
RecruitingPhase 1
Ages 18 to 120 · All sexes · Updated Oct 6, 2026 · NCT06479811A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06234605Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT05287945A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK)
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07401875A Study of Theranostic Pair PD-32766D/T in Participants With Carbonic Anhydrase IX Positive Clear Cell Renal Cell Carcinoma
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07688187Photodynamic Diagnosis of Upper Tract Urothelial Carcinoma Using Fluorescence Endoscopy and Oral 5-ALA
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 18, 2026 · NCT06948552Photodynamic Diagnosis of Kidney Cancer Using Fluorescence Endoscopy and Oral 5-ALA
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 18, 2026 · NCT07828704From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.